GB201504482D0 - Novel formulations - Google Patents

Novel formulations

Info

Publication number
GB201504482D0
GB201504482D0 GB201504482A GB201504482A GB201504482D0 GB 201504482 D0 GB201504482 D0 GB 201504482D0 GB 201504482 A GB201504482 A GB 201504482A GB 201504482 A GB201504482 A GB 201504482A GB 201504482 D0 GB201504482 D0 GB 201504482D0
Authority
GB
United Kingdom
Prior art keywords
novel formulations
formulations
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB201504482A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
Original Assignee
Kings College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London filed Critical Kings College London
Priority to GB201504482A priority Critical patent/GB201504482D0/en
Publication of GB201504482D0 publication Critical patent/GB201504482D0/en
Priority to PCT/GB2016/050682 priority patent/WO2016146981A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB201504482A 2015-03-17 2015-03-17 Novel formulations Pending GB201504482D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201504482A GB201504482D0 (en) 2015-03-17 2015-03-17 Novel formulations
PCT/GB2016/050682 WO2016146981A1 (en) 2015-03-17 2016-03-11 Novel formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201504482A GB201504482D0 (en) 2015-03-17 2015-03-17 Novel formulations

Publications (1)

Publication Number Publication Date
GB201504482D0 true GB201504482D0 (en) 2015-04-29

Family

ID=53016259

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201504482A Pending GB201504482D0 (en) 2015-03-17 2015-03-17 Novel formulations

Country Status (2)

Country Link
GB (1) GB201504482D0 (en)
WO (1) WO2016146981A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
CN1813740B (en) * 2005-11-22 2010-05-05 岳振江 Sublingual pellicles containing naloxone hydrochloride and preparing method thereof
CN101007005A (en) * 2006-01-24 2007-08-01 薛京 Preparation of sublingual administered nalmefene hydrochloride
CN102000037A (en) * 2009-09-03 2011-04-06 北京双鹭立生医药科技有限公司 Sublingual naloxone hydrochloride dripping pill

Also Published As

Publication number Publication date
WO2016146981A1 (en) 2016-09-22

Similar Documents

Publication Publication Date Title
IL273541A (en) Formulations
IL268697A (en) Formulations
IL269630A (en) Niraparib formulations
HK1251559A1 (en) Plinabulin compositions
IL269621A (en) Niraparib formulations
IL265609A (en) Novel formulations
GB201607918D0 (en) Novel formulations
GB201501598D0 (en) Compositions
IL273282A (en) Niraparib formulations
GB201513010D0 (en) Novel formulation
GB201514328D0 (en) Compositions
GB201515387D0 (en) Compositions
GB201707189D0 (en) Novel formulations
GB201515391D0 (en) Compositions
GB201419261D0 (en) Formulations
GB201419091D0 (en) Formulations
IL253635A0 (en) Novel cyclopropabenzofuranyl pyridopyrazinediones
GB201707188D0 (en) Novel formulations
GB201707187D0 (en) Novel formulations
GB2538335B (en) Compositions
HUE050837T2 (en) Compositions
GB201716291D0 (en) Novel formulations
GB201617866D0 (en) Novel formulations
GB201616509D0 (en) Novel formulations
GB201714461D0 (en) Formulations